OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Influence of N -acetyltransferase 2 polymorphisms and clinical variables on liver function profile of tuberculosis patients
Levin Thomas, Arun Prasath Raju, S. Chaithra, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 3, pp. 263-274
Open Access | Times Cited: 7
Levin Thomas, Arun Prasath Raju, S. Chaithra, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 3, pp. 263-274
Open Access | Times Cited: 7
Showing 7 citing articles:
Pharmacogenomic heterogeneity of N-acetyltransferase 2 : a comprehensive analysis of real world data in Indian tuberculosis patients and from literature and database review
Levin Thomas, S. Chaithra, Y K Batra, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Levin Thomas, S. Chaithra, Y K Batra, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic Cohort
Marco Schiuma, Sofia Dinegro, Vera Battini, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3881-3881
Open Access
Marco Schiuma, Sofia Dinegro, Vera Battini, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3881-3881
Open Access
Pharmacogenomic insights into tuberculosis treatment shows the NAT2 genetic variants linked to hepatotoxicity risk: a systematic review and meta-analysis
Rashmi Mahajan, Anuj Kumar
BMC Genomic Data (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Rashmi Mahajan, Anuj Kumar
BMC Genomic Data (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study
Stefania Cheli, Alessandro Torre, Marco Schiuma, et al.
Clinical Infectious Diseases (2024)
Closed Access | Times Cited: 2
Stefania Cheli, Alessandro Torre, Marco Schiuma, et al.
Clinical Infectious Diseases (2024)
Closed Access | Times Cited: 2
Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis
Levin Thomas, Arun Prasath Raju, Surulivelrajan Mallayasamy, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2024) Vol. 49, Iss. 5, pp. 541-557
Open Access | Times Cited: 1
Levin Thomas, Arun Prasath Raju, Surulivelrajan Mallayasamy, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2024) Vol. 49, Iss. 5, pp. 541-557
Open Access | Times Cited: 1
Isoniazid-induced pancreatitis: A systematic review
Tejaswini Baral, Sonal Sekhar Miraj, Levin Thomas, et al.
Tuberculosis (2024) Vol. 148, pp. 102535-102535
Open Access
Tejaswini Baral, Sonal Sekhar Miraj, Levin Thomas, et al.
Tuberculosis (2024) Vol. 148, pp. 102535-102535
Open Access
Characteristics of isoniazid-induced psychosis: a systematic review of case reports and case series
B Keerthanaa, Rashmi Appaji, Levin Thomas, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 11, pp. 1725-1740
Open Access
B Keerthanaa, Rashmi Appaji, Levin Thomas, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 11, pp. 1725-1740
Open Access
